Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Trial of Induction Chemo Followed by CRT Compared With CRT Alone in Locally Advanced Cervical Cancer"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Mary McCormack
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Mary McCormack
Comments 0
Login to view comments.
Click here to Login
